معرفی
Dr. Nazim Nassar is a Lecturer in Pharmacy Practice at the Faculty of Health. A practising pharmacist and academic, his research focuses on developing advanced controlled-release drug delivery systems for bioactive agents and phytochemicals, particularly in cancer therapy and biologics delivery. His expertise spans molecular pharmacology, drug delivery systems, and cannabinoid-based treatments for conditions like melanoma and chronic diseases. Dr. Nassar holds a PhD from RMIT University and has conducted research at institutions including The Hebrew University of Jerusalem, The Technion, and Monash University.
- Education:
- PhD: Development of an Oral Controlled-Release Drug Delivery Systems for Biologics (RMIT University)
- Prior institutions: Hebrew University of Jerusalem, Technion, Monash University
Research Interests: Dr. Nassar’s work centers on innovative drug delivery systems for biopharmaceuticals, including cannabinoids and bioactive peptides. He explores targeted therapies for cancer (especially melanoma), chronic wound management, and infectious diseases. His research emphasizes overcoming drug targeting limitations and enhancing patient compliance through smart delivery systems.
His publications span topics like cannabinoid mechanisms in melanoma treatment, hydrogel advancements, and antibiotic-inspired antimicrobial peptide delivery. He actively supervises Higher Degree by Research (HDR) candidates in drug delivery and biopharmaceutical development.
Labs/Teams: While specific lab details are not provided, his research collaborations involve interdisciplinary teams focused on nanotechnology, biomaterials, and pharmaceutical innovation.
